title: Chronic heart failure with preserved left ventricular ejection fraction: diagnostic and prognostic value of left atrial size.
abstract: BACKGROUND
  Almost 40% of patients with heart failure (HF) have preserved left ventricular (LV) ejection fraction (EF) and prognosis similar to those with reduced EF. Data on prognostic markers in such patients are limited. We analyzed the prevalence and prognostic value of left atrial (LA) size in this condition.
  
  
  METHODS
  89 normal subjects (Group I), 38 asymptomatic hypertensive patients (Group II) and 183 HF patients with preserved EF (EF >45%) (Group III) were studied. LA diameter (LAD), LV diastolic (LVD) and systolic (LVS) dimensions and mass (LVmass) and EF were measured. E and A wave velocities and E/A were measured. The primary end point was all cause mortality in group III patients.
  
  
  RESULTS
  Groups did not differ in age, gender or EF. Group III patients had larger LAD (4.6+-1.0 cm) compared with both Group I (3.7+/-0.6) and Group II (3.7+/-0.5 cm) (p<0.0001). A markedly enlarged (arbitrarily defined as LAD higher or equal 5 cm) had an odds ratio of 34 (95% CI 8-144) in distinguishing HF patients from normals. After a mean follow-up period of 29+/-27 months, 40 patients (21.9%) died. In Cox univariate analysis, NYHA class (HR 2.8 95% C.I. 1.8-4.3; p<0.0001), diastolic blood pressure (DBP) (HR 0.92 95% C.I. 0.88-0.96; p<0.0001), age (HR 1.059 95% C.I. 1.01-1.11; p=0.02) and LAD (HR 1.72 95% C.I. 1.27-2.3; p=0.0005) were predictors of mortality. LAD predicted survival independently of other variables.
  
  
  CONCLUSIONS
  The left atrium is frequently dilated in HF patients compared with controls despite similar EF. LAD showed powerful prognostic value independent of clinical variables.
authors.affiliation: Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia. Universita' degli Studi di Verona, Verona, Italy, and Department of Clinical Cardiology, Royal Brompton Hospital, National Heart and Lung Institute, London, UK. andrea.rossi@univr.it
authors.forename: Andrea
authors.initials: A
authors.lastname: Rossi
authors.forename: Mariantonietta
authors.initials: M
authors.lastname: Cicoira
authors.forename: Viorel G
authors.initials: VG
authors.lastname: Florea
authors.forename: Giorgio
authors.initials: G
authors.lastname: Golia
authors.forename: Natalia D
authors.initials: ND
authors.lastname: Florea
authors.forename: Ashfaq A
authors.initials: AA
authors.lastname: Khan
authors.forename: Sara T M
authors.initials: ST
authors.lastname: Murray
authors.forename: John T
authors.initials: JT
authors.lastname: Nguyen
authors.forename: Patrick
authors.initials: P
authors.lastname: O'Callaghan
authors.forename: Inder S
authors.initials: IS
authors.lastname: Anand
authors.forename: Andrew
authors.initials: A
authors.lastname: Coats
authors.forename: Piero
authors.initials: P
authors.lastname: Zardini
authors.forename: Corrado
authors.initials: C
authors.lastname: Vassanelli
authors.forename: Michael
authors.initials: M
authors.lastname: Henein
mesh_terms: D000368:Aged; D002908:Chronic Disease; D003331:Coronary Vessels / Q000473:pathology*; D004452:Echocardiography; D005260:Female; D006333:Heart Failure / Q000175:diagnosis* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D015996:Survival Rate; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis* / Q000473:pathology* / Q000503:physiopathology